Earlier this week, I talked about the importance of an innovation ecosystem to support investment into the medical advances of the future. This week’s LinkPad takes a look at the latest chatter on innovation incentives, and the tangible benefits to patients and sustainability throughout the health care system.
- Mary Grealy, president of the Healthcare Leadership Council, applauded the historic decline in Medicare spending growth, and explained how biopharmaceutical advances have enhanced the cost-efficiency of care and improved patient outcomes.
- Pennsylvania Bio president, Christopher P. Molineaux, discussed how providing 12 years of data protection for new biologics ensures companies have an incentive to create new treatments and cures for the most pressing health challenges.
- On Washington Post’s Wonkblog, Dylan Matthews breaks down the numbers from the latest data on private sector research and development investments.
- Forbes reporter, Matthew Herper, examines the cost of inventing and developing a new molecule by examining fifteen years of research spending by 100 pharmaceutical companies.
A policy environment that promotes the cures and treatments for today and tomorrow will help patients enjoy longer, healthier, more active lives. In turn, healthier individuals place less strain on an already overextended health care system. By placing smart investments today, we can look forward to a brighter, healthier future.